Cystatin 8 inhibitors are a class of molecules that specifically target cystatin 8, a member of the cystatin superfamily, which functions primarily as an inhibitor of cysteine proteases. Cystatin 8, also known as cystatin-related epididymal specific protein (CRES), is expressed in the reproductive system, particularly in the epididymis, where it plays a critical role in regulating protease activity related to sperm maturation and reproductive processes. Like other cystatins, cystatin 8 binds to cysteine proteases, such as cathepsins, and inhibits their proteolytic functions. By targeting cystatin 8, inhibitors of this protein are designed to disrupt this protease-inhibitor interaction, modulating the activity of proteases that would otherwise be regulated by cystatin 8.
The structure of cystatin 8 includes a conserved cystatin domain, which is crucial for its ability to bind to and inhibit cysteine proteases. Cystatin 8 inhibitors typically function by binding to this domain or interfering with the structural elements that allow cystatin 8 to interact with proteases. This results in the modulation of protease activities in processes that are regulated by cystatin 8, particularly in the epididymis. Such inhibitors provide valuable insights into the proteolytic control mechanisms within the reproductive system, helping to clarify the biological role of cystatin 8 in processes like sperm maturation and overall reproductive function. The molecular interactions between cystatin 8 and its inhibitors are of significant interest for understanding how protease regulation is maintained in specific tissues and biological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
A potent, irreversible cysteine protease inhibitor that may indirectly affect Cystatin 8 by inhibiting its targets. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
A reversible inhibitor of cysteine, serine, and threonine proteases, potentially modifying the environment in which Cystatin 8 operates. | ||||||
Alloxan monohydrate | 2244-11-3 | sc-254940 | 10 g | $54.00 | ||
Known to induce diabetes in animals, can affect protease regulation and potentially influence Cystatin 8 expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that may indirectly affect the degradation of proteins related to Cystatin 8. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Affects lysosomal acidity, potentially altering cysteine protease activity and indirectly influencing Cystatin 8. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that could indirectly affect Cystatin 8 by altering protease activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Exhibits a broad range of biological activities, potentially affecting pathways related to Cystatin 8. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
A pan-caspase inhibitor that may indirectly influence Cystatin 8 through its impact on apoptosis-related proteases. | ||||||
Cystamine dihydrochloride | 56-17-7 | sc-217990 sc-217990A | 25 g 100 g | $39.00 $105.00 | ||
Acts as an inhibitor of transglutaminase and could influence protease activity, indirectly affecting Cystatin 8. | ||||||
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | $121.00 $456.00 | 28 | |
Inhibits calpain, a cysteine protease, which may indirectly modulate Cystatin 8 activity or expression. | ||||||